Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1976 2
1977 4
1978 2
1979 1
1980 3
1982 3
1983 1
1984 7
1985 4
1986 2
1988 2
1989 3
1990 2
1991 3
1995 1
1996 3
1999 2
2001 1
2002 1
2003 3
2004 2
2005 2
2006 3
2008 2
2009 4
2010 4
2011 9
2012 10
2013 6
2014 4
2015 3
2016 4
2017 2
2018 3
2019 2
2020 2
2021 7
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
Nowell J, Blunt E, Gupta D, Edison P. Nowell J, et al. Ageing Res Rev. 2023 Aug;89:101979. doi: 10.1016/j.arr.2023.101979. Epub 2023 Jun 14. Ageing Res Rev. 2023. PMID: 37328112 Free article. Review.
Alongside insulin signalling, targeting incretin receptors in the brain represents one of the most promising strategies for repurposing currently available agents for the treatment of AD/PD. Most notably, glucagon-like-peptide-1 (GLP-1) receptor agonists have displayed imp …
Alongside insulin signalling, targeting incretin receptors in the brain represents one of the most promising strategies for repurposing curr …
Dasiglucagon Hydrochloride.
[No authors listed] [No authors listed] Am J Health Syst Pharm. 2021 Jul 22;78(15):1351-1353. doi: 10.1093/ajhp/zxab198. Am J Health Syst Pharm. 2021. PMID: 33998648 No abstract available.
Pharmacotherapy of obesity: An update.
Cignarella A, Busetto L, Vettor R. Cignarella A, et al. Pharmacol Res. 2021 Jul;169:105649. doi: 10.1016/j.phrs.2021.105649. Epub 2021 May 4. Pharmacol Res. 2021. PMID: 33962014 Review.
Further strategies including multiagonists able to simultaneously target multiple actors involved in obesity initiation and expansion such as the glucagon receptor family are under investigation. The results of recent clinical trials are encouraging and highlight emerging …
Further strategies including multiagonists able to simultaneously target multiple actors involved in obesity initiation and expansion such a …
The usefulness of glucagon hydrochloride for colonic distention in CT colonography.
Yee J, Hung RK, Akerkar GA, Wall SD. Yee J, et al. AJR Am J Roentgenol. 1999 Jul;173(1):169-72. doi: 10.2214/ajr.173.1.10397121. AJR Am J Roentgenol. 1999. PMID: 10397121 Clinical Trial.
OBJECTIVE: The purpose of this study was to compare colonic distention with and without glucagon hydrochloride during CT colonography. SUBJECTS AND METHODS: CT colonography using single breath-hold, thin-section helical technique was performed on 60 patients who wer …
OBJECTIVE: The purpose of this study was to compare colonic distention with and without glucagon hydrochloride during CT colon …
Tarka (trandolapril/verapamil hydrochloride extended-release) overdose.
Cohen V, Jellinek SP, Fancher L, Sangwan G, Wakslak M, Marquart E, Farahani C. Cohen V, et al. J Emerg Med. 2011 Mar;40(3):291-5. doi: 10.1016/j.jemermed.2008.10.015. Epub 2009 Feb 26. J Emerg Med. 2011. PMID: 19249183 Review.
Therapy for CCB toxicity was initiated, including fluids, modified hyperglycemia-euglycemia insulin therapy, calcium chloride, activated charcoal, and glucagon. The patient's blood pressure and heart rate stabilized only after the administration and titration of dopamine a …
Therapy for CCB toxicity was initiated, including fluids, modified hyperglycemia-euglycemia insulin therapy, calcium chloride, activated cha …
Gateways to clinical trials.
Bayés M, Rabasseda X, Prous JR. Bayés M, et al. Methods Find Exp Clin Pharmacol. 2004 Jan-Feb;26(1):53-84. Methods Find Exp Clin Pharmacol. 2004. PMID: 14988742 Review.
This issue focuses on the following selection of drugs: Abetimus sodium, Ad5-FGF4, adeno-Interferon gamma, AE-941, AERx, alemtuzumab, alicaforsen sodium, almotriptan, alpharadin, anakinra, anatumomab mafenatox, ANG-453, anti-CTLA-4 Mab, AP-12009, aprepitant, aripiprazole, arsenic …
This issue focuses on the following selection of drugs: Abetimus sodium, Ad5-FGF4, adeno-Interferon gamma, AE-941, AERx, alemtuzumab, alicaf …
Use of non-insulin therapies for type 1 diabetes.
Garg SK, Michels AW, Shah VN. Garg SK, et al. Diabetes Technol Ther. 2013 Nov;15(11):901-8. doi: 10.1089/dia.2013.0281. Epub 2013 Oct 16. Diabetes Technol Ther. 2013. PMID: 24131372 Review. No abstract available.
Effect of Landiolol Hydrochloride on Hemodynamics in a Histamine-Induced Shock Model.
Hirano M, Okamura T, Nagano T, Nonaka S, Shiroya T. Hirano M, et al. Drugs R D. 2021 Sep;21(3):321-329. doi: 10.1007/s40268-021-00354-3. Epub 2021 Jun 14. Drugs R D. 2021. PMID: 34128200 Free PMC article.
In this study, we sought to analyze anaphylactic shock treatment in patients receiving short-acting beta1-blockers. METHODS: We examined the influence of epinephrine and glucagon on hemodynamics during beta-blocker treatment, using a dog histamine shock model; the beta1-bl …
In this study, we sought to analyze anaphylactic shock treatment in patients receiving short-acting beta1-blockers. METHODS: We examined the …
Top 20 Research Studies of 2021 for Primary Care Physicians.
Ebell MH, Grad R. Ebell MH, et al. Am Fam Physician. 2022 Jul;106(1):61-69. Am Fam Physician. 2022. PMID: 35839363
This article summarizes the top 20 research studies of 2021 identified as POEMs (patient-oriented evidence that matters) that did not address the COVID-19 pandemic. Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists prevent adverse card …
This article summarizes the top 20 research studies of 2021 identified as POEMs (patient-oriented evidence that matters) that did not addres …
Colon distension, perceived burden and side-effects of CT-colonography for screening using hyoscine butylbromide or glucagon hydrochloride as bowel relaxant.
de Haan MC, Boellaard TN, Bossuyt PM, Stoker J. de Haan MC, et al. Eur J Radiol. 2012 Aug;81(8):e910-6. doi: 10.1016/j.ejrad.2012.05.020. Epub 2012 Jun 9. Eur J Radiol. 2012. PMID: 22683196
OBJECTIVE: Compare colonic distension and perceived burden of CT-colonography between participants receiving hyoscine butylbromide (buscopan) and glucagon hydrochloride as bowel relaxant. MATERIALS AND METHODS: Data were collected within a screening trial. ...RESULT …
OBJECTIVE: Compare colonic distension and perceived burden of CT-colonography between participants receiving hyoscine butylbromide (buscopan …
118 results